NO950985D0 - Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer - Google Patents

Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer

Info

Publication number
NO950985D0
NO950985D0 NO950985A NO950985A NO950985D0 NO 950985 D0 NO950985 D0 NO 950985D0 NO 950985 A NO950985 A NO 950985A NO 950985 A NO950985 A NO 950985A NO 950985 D0 NO950985 D0 NO 950985D0
Authority
NO
Norway
Prior art keywords
metabolizable
tamoxifen
treatment
resistant tumors
clomiphene analogues
Prior art date
Application number
NO950985A
Other languages
English (en)
Other versions
NO950985L (no
Inventor
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO950985L publication Critical patent/NO950985L/no
Publication of NO950985D0 publication Critical patent/NO950985D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45Monoamines
    • C07C211/48N-alkylated amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO950985A 1992-09-15 1995-03-14 Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer NO950985D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94530592A 1992-09-15 1992-09-15
PCT/US1993/007697 WO1994006762A1 (en) 1992-09-15 1993-08-16 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors

Publications (2)

Publication Number Publication Date
NO950985L NO950985L (no) 1995-03-14
NO950985D0 true NO950985D0 (no) 1995-03-14

Family

ID=25482938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950985A NO950985D0 (no) 1992-09-15 1995-03-14 Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer

Country Status (16)

Country Link
US (2) US5410080A (no)
EP (1) EP0660821B1 (no)
JP (1) JPH09500863A (no)
KR (1) KR100326962B1 (no)
AT (1) ATE162516T1 (no)
AU (1) AU672234B2 (no)
CA (1) CA2143000C (no)
DE (1) DE69316633T2 (no)
DK (1) DK0660821T3 (no)
ES (1) ES2112994T3 (no)
FI (1) FI951193A (no)
GR (1) GR3026236T3 (no)
HU (1) HUT71244A (no)
NO (1) NO950985D0 (no)
NZ (1) NZ255785A (no)
WO (1) WO1994006762A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR008155A1 (es) * 1996-09-06 1999-12-09 Smithkline Beecham Corp Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
HUP0002852A3 (en) 1997-08-15 2001-11-28 Univ Durham A method of preventing or treating estrogen-dependent diseases and disorders using triphenil-ethylene derivatives
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
CA2889770A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Trans-clomiphene for use in cancer therapy
US9914696B2 (en) 2014-03-11 2018-03-13 Repros Therapeutics Inc. Clomiphene synthesis using a single solvent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750416A (en) * 1950-12-21 1956-06-12 Rohm & Haas Aminomethylphenols and method for their preparation
US3143568A (en) * 1961-01-25 1964-08-04 Vismara Francesco Spa Diarylamino-acetyl-aryl derivatives
US3244705A (en) * 1962-11-14 1966-04-05 Richardson Merrell Inc Triphenylhaloethylene derivatives
CH373975A (de) * 1963-07-20 1963-12-15 Heierle Werner Kronen-Verschluss für Flaschen
FR3575M (fr) * 1964-01-28 1965-10-04 Richardson Merrell Triphénylhalogénoéthylenes substitués.
US3631109A (en) * 1968-12-04 1971-12-28 Uniroyal Inc Beta beta'-bis(dialkylaminomethyl-4-hydroxy-benzylthio)dialkylethers
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors

Also Published As

Publication number Publication date
ATE162516T1 (de) 1998-02-15
FI951193A0 (fi) 1995-03-14
EP0660821B1 (en) 1998-01-21
DE69316633T2 (de) 1998-05-20
AU5015093A (en) 1994-04-12
AU672234B2 (en) 1996-09-26
KR100326962B1 (ko) 2002-12-02
HUT71244A (en) 1995-11-28
FI951193A (fi) 1995-03-14
WO1994006762A1 (en) 1994-03-31
DE69316633D1 (de) 1998-02-26
CA2143000A1 (en) 1994-03-31
HU9500775D0 (en) 1995-05-29
ES2112994T3 (es) 1998-04-16
KR950703524A (ko) 1995-09-20
CA2143000C (en) 2000-03-28
GR3026236T3 (en) 1998-05-29
US5681863A (en) 1997-10-28
US5410080A (en) 1995-04-25
NO950985L (no) 1995-03-14
NZ255785A (en) 1997-05-26
EP0660821A1 (en) 1995-07-05
JPH09500863A (ja) 1997-01-28
DK0660821T3 (da) 1998-09-21

Similar Documents

Publication Publication Date Title
MY102087A (en) Phenethanolamine derivatives.
RU94036774A (ru) Ингибирование пролиферации клеток гладкой мускулатуры и рестеноза
EP0107201A3 (en) Phenyl-substituted tricyclic antibacterial agents
CO4410321A1 (es) Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos
DK0593478T3 (da) Leukotrien-B4-antagonister
PT95584A (pt) Processo de preparacao de antraquinonas, dos seus intermediarios e de composicoes farmaceuticas
ES8802014A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
CA2149872A1 (en) Diabetes prevention and treatment
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
NO950985L (no) Ikke-metaboliserbare klomifenanaloger for behandling av tamoxifenresistente tumorer
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
ZA902649B (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
ES8303316A1 (es) Un procedimiento para la fabricacion de un disulfuro intra ointermolecular
PT900082E (pt) Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania
SE8205868D0 (sv) A titre de medicaments, certains derives de lŸacide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
ES8605800A1 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
DE3277694D1 (en) Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
ES2006099A6 (es) Procedimiento para la obtencion de hidrocloruro de ciprofloxacina monohidrato.
SE8302452D0 (sv) Method for treatment of senile dementia
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
FR2455598A1 (fr) Nouveaux derives 5- (2- ((2,3-dihydro-1,4-benzodioxanne-2-ylmethyl)- amino)-1- hydroxyethyl)-2-hydroxybenzoiques, utiles notamment comme agents bloquants des recepteurs adrenergiques a et b, et leur procede de preparation
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
JPS579782A (en) Novel compound
JPS5430169A (en) 2-aminoalkyl-5-phenyloxazoles and their pharmaceutically acceptable aicd salts

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application